Correlation Between Forte Biosciences and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Forte Biosciences and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Forte Biosciences and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Forte Biosciences and Processa Pharmaceuticals, you can compare the effects of market volatilities on Forte Biosciences and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Forte Biosciences with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Forte Biosciences and Processa Pharmaceuticals.

Diversification Opportunities for Forte Biosciences and Processa Pharmaceuticals

0.92

Correlation Coefficient

Forte Biosciences  Processa Pharmaceuticals

Almost no diversification

The 3 months correlation between Forte and Processa is 0.92. Overlapping area represents the amount of risk that can be diversified away by holding Forte Biosciences and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Forte Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Forte Biosciences are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Forte Biosciences i.e., Forte Biosciences and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Forte Biosciences and Processa Pharmaceuticals

Given the investment horizon of 90 days Forte Biosciences is expected to generate 1.93 times more return on investment than Processa Pharmaceuticals. However, Forte Biosciences is 1.93 times more volatile than Processa Pharmaceuticals. It trades about -0.15 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.28 per unit of risk. If you would invest  2,114  in Forte Biosciences on December 28, 2024 and sell it today you would lose (1,364) from holding Forte Biosciences or give up 64.52% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	98.36%
Values	Daily Returns

Forte Biosciences  vs.  Processa Pharmaceuticals

Forte Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Forte Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Processa Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Forte Biosciences and Processa Pharmaceuticals

The main advantage of trading using opposite Forte Biosciences and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Forte Biosciences position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Forte Biosciences and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.